Japan's Icom says it hasn't sold walkie-talkies that exploded in Lebanon in a decade
By Megumi Fujikawa
Japanese radio equipment maker Icom said it no longer produces or sells two-way radio devices which reportedly exploded in Lebanon.
The company Thursday said it had produced and sold the IC-V82 hand-held radio in the overseas markets, including the Middle East, from 2004 to October 2014.
It has since stopped selling the product and ended production of the batteries needed to operate the main unit.
"A hologram seal to distinguish counterfeit products was not attached, so it is not possible to confirm whether the product shipped from our company," the company said.
Icom's (JP:6820) statement was in response to media reports that walkie-talkies bearing Icom's logo had exploded in Lebanon.
Walkie-talkies used by the Hezbollah blew up in homes, cars and in operatives' hands across the country on Wednesday, the Wall Street Journal reported, citing people familiar with the matter. That came a day after thousands of pagers carried by Hezbollah members exploded at roughly the same time.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-19-24 0338ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk